Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)
Monkeypox Biology, Outcome, Transmission and Epidemiology (MBOTE) Study: Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)
Institute of Tropical Medicine, Belgium
1,000 participants
Mar 28, 2025
OBSERVATIONAL
Conditions
Summary
This study aims to better understand how mpox is spreading in the DRC, how it affects different groups of people, and how well vaccines protect against it. The study is designed as a cross-sectional survey, meaning researchers will collect and analyze data from patients diagnosed with mpox at a single point in time. It will also use a case-control approach, comparing people who test positive for the virus to those who test negative, to identify risk factors and evaluate the effectiveness of the vaccine.
Eligibility
Inclusion Criteria3
- Apply to be tested for VMPX at HGR or another test center.
- Patients of all ages and sexes. However, minors under the age of 12 are excluded from questions on sex life.
- The patient or his/her culturally acceptable representative is willing and able to give informed consent for participation in the study.
Exclusion Criteria1
- NA
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06840860